Artificial intelligence could be new blueprint for precision drug discovery

Researchers have described a new approach that uses machine learning to hunt for disease targets and then predicts whether a drug is likely to receive FDA approval.

source https://www.sciencedaily.com/releases/2021/07/210712130142.htm